We are investigating the fairness of the proposed sale of Kenvue Inc. (NYSE: KVUE) (“Kenvue”) to Kimberly-Clark pursuant to which Kenvue shareholders will receive $3.50 per share in cash as well as 0.14625 Kimberly-Clark shares for each Kenvue share held at closing, for an implied sale price of $21.01 per share, based on the closing price of Kimberly-Clark shares as of October 31, 2025.
Kimberly-Clark shares, however, have fallen since the deal was announced, thus reducing the value of the consideration to Kenvue stockholders. Moreover, the implied sale price is below Kenvue’s 52-week high of $25.17 per share, which suggests an opportunistic purchase.
If you remain a Kenvue shareholder and have concerns about the fairness of the proposed merger, you may contact our firm to discuss your legal rights at no charge by completing and submitting the form below.
Why is there an investigation?
On November 3, 2025, Kenvue announced that it had agreed to be sold to Kimberly-Clark in a transaction pursuant to which Kenvue shareholders will receive $3.50 per share in cash as well as 0.14625 Kimberly-Clark shares for each Kenvue share held at closing, for an implied sale price of $21.01 per share, based on the closing price of Kimberly-Clark shares as of October 31, 2025.
Kimberly-Clark shares, however, have fallen since the deal was announced, thus reducing the value of the consideration to Kenvue stockholders. Moreover, the implied sale price is below Kenvue’s 52-week high of $25.17 per share, which suggests an opportunistic purchase.
“We are investigating whether the Kenvue Board of Directors acted in the best interests of Kenvue shareholders in approving the merger,” explained Joshua Fruchter, a founding partner of Wohl & Fruchter. “This includes whether the exchange ratio agreed upon is fair to Kenvue shareholders, and whether all material information regarding the transaction has been fully disclosed.”